Human Leukemia Inhibitory Factor Receptor (LIFR) Protein

Este producto es parte de LIFR - LIF receptor subunit alpha
Human Leukemia Inhibitory Factor Receptor (LIFR) Protein
208€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Human Leukemia Inhibitory Factor Receptor (LIFR) Protein
Category
Proteins and Peptides
Provider
Abbexa
Reference
abx067772
Tested Applications
WB, SDS-PAGE

Description

Human Leukemia Inhibitory Factor Receptor (LIFR) is a recombinant Human protein expressed in E. coli.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Proteins and Peptides
Immunogen Target
Leukemia Inhibitory Factor Receptor (LIFR)
Host
E. coli
Assay Type
Activity: Not tested
Sequence Fragment: Gln45-Leu184
Tag: N-terminal His tag
Origin
Human
Conjugation
Unconjugated
Observed MW
Calculated MW: 17.4 kDa
Expression
Recombinant
Purity
> 95%
Size 1
10 µg
Size 2
50 µg
Size 3
100 µg
Size 4
200 µg
Size 5
500 µg
Form
Lyophilized
Tested Applications
WB, SDS-PAGE
Buffer
Prior to lyophilization: PBS, pH 7.4, containing 0.01% Sarcosyl, 1 mM DTT, 5% Trehalose and Proclin-300.
Availability
Shipped within 5-7 working days.
Storage
Store lyophilized form at 2-8°C for up to 1 month. For longer periods, store lyophilized or liquid at -80°C. Avoid repeated freeze–thaw cycles.
Dry Ice
No
UniProt ID
P42702
Alias
Leukemia inhibitory factor receptor,SWS,SJS2,STWS,CD118,LIF-R,LIF receptor
Background
Protein LIFR
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
To keep the original salt concentration, we recommend reconstituting to the original concentration prior to lyophilization (see Concentration) in ddH2O. If a lower concentration is required, dilute in PBS, pH 7.4. If a higher concentration is required, the product can be reconstituted directly in PBS, pH 7.4, though please note that this will change the overall salt concentration. The stock concentration should be between 0.1-1.0 mg/ml. Do not vortex.
Concentration: Prior to lyophilization: 200 µg/ml

Background

The leukemia inhibitory factor receptor (LIFR), also known as the LIF receptor subunit alpha, is a component of a cytokine receptor complex responsible for mediating the effects of the leukemia inhibitory factor (LIF). LIF is part of the interleukin-6 (IL-6) family of cytokines and is involved in various cellular processes, such as cell survival, proliferation, and differentiation, particularly in neuronal, hematopoietic, and reproductive cells. LIFR is encoded by the LIFR gene, located on chromosome 5p13, and is widely expressed across various tissues, including the placenta, brain, liver, and bone marrow. LIFR functions as a non-signaling receptor subunit and, upon binding to LIF, associates with the co-receptor gp130. Together, this receptor complex initiates intracellular signaling pathways that are central to immune responses, tissue repair, and neural development. LIFR is significant in embryonic development and stem cell maintenance, and dysregulation of LIFR signaling is associated with several diseases, such as inflammatory disorders, cancer, and neurodegenerative diseases.

Productos relacionados

abx067764

Mouse Leukemia Inhibitory Factor Receptor (LIFR) Protein

Mouse Leukemia Inhibitory Factor Receptor (LIFR) is a recombinant Mouse protein expressed in E. coli.…

Ver producto
abx067765

Rat Leukemia Inhibitory Factor Receptor (LIFR) Protein

Rat Leukemia Inhibitory Factor Receptor (LIFR) is a recombinant Rat protein expressed in E. coli.…

Ver producto
abx067766

Human Leukemia Inhibitory Factor Receptor (LIFR) Protein

Human Leukemia Inhibitory Factor Receptor (LIFR) is a recombinant Human protein expressed in E. coli.…

Ver producto